Home › AOTI LIMITED › Hyperbox System
Hyperbox System
AOTI LIMITED · Model Hyperbox System, 115VAC · UDI-DI 05391518740027
KPJ
Prescription
10
510(k) clearances
2
Adverse events
2
Recalls
17
Facilities
Description
The Hyper-Box Topical Wound Oxygen System is intended to be used for the treatment of acute and chronic wounds, such as; o skin ulcerations due to diabetes, venous stasis, post surgical infections and gangrenous lesions o decubitus ulcers o amputations/infected stumps o skin grafts o burns o frostbite The Hyper-Box Topical Wound Oxygen controller regulates the oxygen pressure and the duration of treatment inside the extremity chamber in accordance with the physician’s orders.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2012-04-16 | Ogenix Corporation | Ogenix Initiated a voluntary recall for the EPIFLO-15 devices due to a mislabeling of the expiry date for this lot. Instead of March 2013, this lot carried May 2013 as the expiry d |
| 2006-03-24 | Ogenix Corporation | Conflicting instructions are provided in the Instructions for Use (IFU) and the Clinical Users Guide (CUG) which accompany the EpiFLO device. Consequently, the firm removed the CUG |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.